Biomarkers for Drug Discovery & Development | Webinars
High-Throughput Biomarker Discovery for Clinical Trial Optimization
On-Demand Webinar featuring Dr Mo Jain, Founder & CEO of Sapient
This webinar shares how next-generation, high throughput mass spectrometry, advanced data analysis, and population-scale data are being leveraged for robust discovery of biomarkers that can be used to align patients, disease biology, and therapeutic interventions for clinical trials.
This webinar shares how next-generation, high throughput mass spectrometry, advanced data analysis, and population-scale data are being leveraged for robust discovery of biomarkers that can be used to align patients, disease biology, and therapeutic interventions for clinical trials.
In this webinar, Dr Mo Jain will share how Sapient has established discovery-as-a-service approaches that utilize next-generation, high throughput mass spectrometry, advanced data analysis, and population-scale data assets across more than 100,000 individuals to enable robust discovery of biomarkers that can be used to align patients, disease biology, and therapeutic interventions for clinical trials.
You will learn about:- The role of small molecule biomarkers in providing insight into human disease biology and drug response
- Technologies enabling rapid identification of small molecule biomarkers of biological processes, disease progression, and drug response, including for clinical trial optimization
- Real-world examples of how Sapient’s small molecule biomarker discovery approaches have been used to advance clinical trials
